Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.
about
Phosphate and FGF-23The role of phosphorus in the development and progression of vascular calcificationCardiovascular Risk Factors and Chronic Kidney Disease-FGF23: A Key Molecule in the Cardiovascular DiseaseVascular calcification: When should we interfere in chronic kidney disease patients and how?Stop chronic kidney disease progression: Time is approachingVascular calcification in chronic kidney disease: role of disordered mineral metabolism.FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability.Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients.The bone-vascular axis in chronic kidney disease.Association of fibroblast growth factor-23 with arterial stiffness in the Multi-Ethnic Study of AtherosclerosisRelationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney DiseaseCalcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients.Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional studyA low fractional excretion of Phosphate/Fgf23 ratio is associated with severe abdominal Aortic calcification in stage 3 and 4 kidney disease patients.Association of Serum Phosphate and Related Factors in ESRD-Related Vascular CalcificationFGF-23 associated with the progression of coronary artery calcification in hemodialysis patients.Association of serum phosphorus variability with coronary artery calcification among hemodialysis patients.FGF-23: More than a regulator of renal phosphate handling?Magnesium and FGF-23 are independent predictors of pulse pressure in pre-dialysis diabetic chronic kidney disease patients.Low Magnesium Levels and FGF-23 Dysregulation Predict Mitral Valve Calcification as well as Intima Media Thickness in Predialysis Diabetic PatientsFGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness.The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney DiseaseSerum Phosphorus Concentration and Coronary Artery Calcification in Subjects without Renal DysfunctionHigh-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification.Association of circulating fibroblast growth factor-23 with renal phosphate excretion among hemodialysis patients with residual renal functionPlasma FGF23 and Calcified Atherosclerotic Plaque in African Americans with Type 2 Diabetes Mellitus.Aortic Artery and Cardiac Valve Calcification are Associated with Mortality in Chinese Hemodialysis Patients: A 3.5 Years Follow-up.Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.Vascular calcification in chronic kidney disease: Pathogenesis and clinical implicationRegression of vascular calcification in chronic kidney disease - feasible or fantasy? a review of the clinical evidence.Biomarkers of vascular calcification and mortality in patients with ESRD.Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative reviewDisorders of phosphorus homeostasis.Is fibroblast growth factor 23 a harbinger of mortality in CKD?Fibroblast growth factor 23 as a phosphotropic hormone and beyond.Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk.Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications.Phosphate handling in CKD-MBD from stage 3 to dialysis and the three strengths of lanthanum carbonate.Review of cinacalcet hydrochloride in the management of secondary hyperparathyroidism.Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.
P2860
Q24610674-60763E5C-A12F-461B-9139-7F1952E4FB05Q26823897-A78F52D9-0F7E-498A-AE80-B4B679DCE6DBQ27024043-C26D4A5D-6E21-45BB-BC0C-78322D53BAC7Q28071582-1544718B-BB65-40B6-8A1C-F3CFE2E0A505Q28078020-BEC8CB71-F3FD-4E48-9D82-D03791081848Q34037021-3F4A9FF6-63B1-4521-824A-EF077EC90A31Q34130840-265679BC-98ED-4AC0-B0F7-B3362084AE34Q34261737-6F171752-40AA-41FD-9135-9FE5DD6D8930Q34402808-586D04D3-D6D6-4C77-B317-D7486D0FFCC7Q34406871-87C83D89-2D4E-43CE-9332-5411FD8F71EAQ34479134-B59B9F6D-951E-4300-A3CD-9F89E628CED1Q34547461-21EE0484-108C-47EF-A64F-4D76C1B10FD1Q34557041-74E5EF45-12EA-406B-8862-C2661488B720Q35015899-77D85C4C-E218-4098-99C3-6BA0048EAE5FQ35024959-CD57B738-23A6-43C5-ABF0-F05997CB4FA0Q35030290-38D92337-400C-4269-9DD5-2AAC87F08C53Q35152692-1DC87346-F796-48DD-A4CD-4EF05983DD71Q35156017-00C1315A-7040-4E4C-AA54-0DE5B5DD9607Q35227631-A6AA9866-0D4D-4EA3-9E5F-C3DA8389C40CQ35671325-75DDA8A9-4D62-4C2E-8962-54B6AAFAB979Q35804988-3A2DBA06-A19A-4AD0-A585-F58B46B6CD3FQ35914820-84F387B9-8559-452F-BD55-0D5A11425F4AQ35963073-5F8D3A31-DD77-4345-B1D8-69D9DD776A35Q36287699-EE0D5F0A-C484-431F-9B18-9AFE0B7C8BA6Q36492520-10C30F0A-E160-4790-BABA-FDF5D120FE98Q36520483-45DC578F-DDF4-4F3C-B8D7-87755C238829Q36531867-13E86600-F85E-4ECC-ABA0-C9E29BB06D40Q36901897-4923A179-96E1-463E-893C-3AE55A4289A5Q37195354-0EE4FAC2-9D7B-4E8D-9EE9-A504A38B76D3Q37219046-1E49DDA3-90AC-4015-A30D-307D8173911DQ37682232-3EC23BD7-5AB1-4896-8D98-4A97FE15F4F2Q37695914-67094BF4-9DD0-4AB3-9C2A-EFB048AA8748Q37801814-8C45A5C9-6B2A-41F0-B2E9-5F7E45EA1E13Q37851395-0C459AE7-2CE0-4EBE-BA4A-5F1DB8803DA8Q37913097-8036DC01-F483-444F-94D5-16A61182F478Q38009044-BC29FC77-AF49-4E92-BD6C-75DFD25FF985Q38016491-D7F22067-77B6-4F33-856F-40203A8BC1B7Q38049170-88179599-1F82-475D-AD08-897B6ACC2C81Q38141236-1479198D-B0F9-483C-AEFD-7BAD8EC13CF7Q38200883-7D896E43-BAEB-4263-9EE1-22A895BCFA4D
P2860
Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Fibroblast growth factor-23 (F ...... ion in haemodialysis patients.
@en
Fibroblast growth factor-23
@nl
type
label
Fibroblast growth factor-23 (F ...... ion in haemodialysis patients.
@en
Fibroblast growth factor-23
@nl
prefLabel
Fibroblast growth factor-23 (F ...... ion in haemodialysis patients.
@en
Fibroblast growth factor-23
@nl
P2093
P2860
P356
P1476
Fibroblast growth factor-23 (F ...... ion in haemodialysis patients.
@en
P2093
Amal R El-Shehaby
Esam El Sheikh
Mohamed M Nasrallah
Mona M Salem
Noha A Osman
Usama A A Sharaf El Din
P2860
P304
P356
10.1093/NDT/GFQ089
P407
P577
2010-02-22T00:00:00Z